Investigating the genetic and environmental factors in kidney scarring

Epigenetic mechanisms in a novel model of FSGS

NIH-funded research St. Louis VA Medical Center · NIH-10924486

This study is looking into how both genes and early life experiences can affect kidney health in people with focal segmental glomerulosclerosis (FSGS), especially in African Americans, to help find better ways to treat or prevent this condition.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionSt. Louis VA Medical Center NIH-funded
Lab location1 site (St. Louis, UNITED STATES)
Project IDNIH-10924486 on NIH RePORTER

What this research studies

This research focuses on understanding focal segmental glomerulosclerosis (FSGS), a condition characterized by scarring in the kidneys. It aims to explore how genetic and environmental factors contribute to this disease, particularly in African American populations who are disproportionately affected. The study will examine the role of developmental programming, which refers to how early life conditions can influence kidney health later in life. By identifying the molecular mechanisms involved, the research seeks to pave the way for new therapeutic approaches to treat or prevent FSGS.

Who could benefit from this research

Good fit: Ideal candidates for this research include African American individuals with a history of kidney issues or those at risk for developing FSGS.

Not a fit: Patients with FSGS who do not belong to the targeted demographic or those with well-defined causes of their kidney disease may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments for kidney scarring and better health outcomes for patients at risk of kidney disease.

How similar studies have performed: Previous research has shown promise in understanding the genetic and environmental factors affecting kidney diseases, suggesting that this approach could yield valuable insights.

Where this research is happening

St. Louis, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Autoimmune Diseases
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.